Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AMPK
    (4)
  • Apoptosis
    (1)
  • JAK
    (1)
  • YAP
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

nuak2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    7
    TargetMol | Inhibitors_Agonists
WZ4003
T62911214265-58-3
WZ4003, a highly selective NUAK kinase inhibitor, is with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2, respectively. It is no significant inhibition on 139 other kinases.
  • Inquiry Price
Size
QTY
HTH-01-015
T23741613724-42-7In house
HTH-01-015 is a selective NUAK1 inhibitor with an IC50 of 100 nM.
  • Inquiry Price
Size
QTY
MRT199665
T161421456858-57-3In house
MRT199665 is an effective and ATP-competitive, selective MARK SIK AMPK inhibitor (IC50s of 2 2 3 2 nM, 10 10 nM, and 110 12 43 nM for MARK1 MARK2 MARK3 MARK14, AMPKα1 AMPKα2, and SIK1 SIK2 SIK3, respectively). MRT199665 suppresses the phosphorylation of S
  • Inquiry Price
8-10 weeks
Size
QTY
KHKI-01215
KHKI01215
T201397
KHKI-01215 is an effective NUAK2 inhibitor with anticancer activity, inhibiting the proliferation of SW480 cancer cells and inducing apoptosis in SW480 cells. KHKI-01215 is used for cancer research.
  • Inquiry Price
Size
QTY
UCB9386
T204179
UCB9386 is a brain-penetrant and selective inhibitor of Nuak1, with a pIC50 of 10.1. It also inhibits Nuak2 and Kak2, showing approximately 50% inhibition at 10 nM.
  • Inquiry Price
Size
QTY
HTH-02-006
T82165
HTH-02-006, a NUAK2 inhibitor (IC50 = 126 nM), decreases phosphorylated MYPT1 levels in HuCCT-1 cells and inhibits YAP-driven cell proliferation, hepatomegaly, and tumorigenesis. Additionally, it possesses an antifibrotic protective effect [1] [2].
  • Inquiry Price
Size
QTY
KHKI-01128
T89125
KHKI-01128 is a NUAK2 inhibitor with an IC50 of 0.024 μM. It demonstrates effective anticancer activity against SW480 colorectal cancer cells.
  • Inquiry Price
Size
QTY